DTPC2Q1 Crome HF Quad
Cardiac Resynchronization Therapy - Defibrillation (CRT-Defib)
DTPC2Q1 Crome HF Quad
Information

Device Survival Probability

Loading...










   
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Information

Product Characteristics

Generator Type CRT-Defib
NBD Code
Max. Delivered Energy
More
Serial Number Prefix RTT
Mass
Volume
Waveform
X-Ray ID
Hide this content
Information

Estimated Longevity

Charging Frequency 100% Pacing 50% Pacing 15% Pacing 100% Sensing
Monthly
Quarterly
Semi-annual
Information

Distribution Data

US Market Release
CE Approval Date
Registered USA Implants40
Estimated Active USA Implants39
Normal Battery Depletions
US Market Release
CE Approval Date
Estimated WW Distribution73
Normal Battery Depletions
Information

Malfunctions (USA)

Therapy Function Not Compromised
Therapy Function Compromised
Information

Malfunctions (WW)

Therapy Function Not Compromised
Therapy Function Compromised
Information

EOL Indicator

Information

Elective Replacement (ERI)

Data as of May 19, 2021

www.medtronic.com/productperformance 801050